UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.978

Sortiert nach

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Gut, 2013-01, Vol.62 (1), p.112-120

2013

Volltextzugriff (PDF)

A recombinant human enzyme for enhanced interstitial transport of therapeutics

Journal of controlled release, 2006-08, Vol.114 (2), p.230-241

2006

Volltextzugriff (PDF)

Humanization of an anti-p185HER2 antibody for human cancer therapy

Proceedings of the National Academy of Sciences - PNAS, 1992-05, Vol.89 (10), p.4285-4289

1992

Volltextzugriff (PDF)

p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus

Clinical cancer research, 1998-07, Vol.4 (7), p.1649-1659

1998

Volltextzugriff (PDF)

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

Breast cancer research and treatment, 1992-01, Vol.24 (2), p.85-95

1992

Volltextzugriff (PDF)

Herceptin

Handbook of experimental pharmacology, 2008 (181), p.183

2008

Volltextzugriff (PDF)

Tumor Necrosis Factor: A Potent Effector Molecule for Tumor Cell Killing by Activated Macrophages

Proceedings of the National Academy of Sciences - PNAS, 1986-07, Vol.83 (14), p.5233-5237

1986

Volltextzugriff (PDF)

Macrophage-induced angiogenesis is mediated by tumour necrosis factor- α

Nature (London), 1987-10, Vol.329 (6140), p.630-632

1987

Volltextzugriff (PDF)

Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

International journal of cancer, 1996-09, Vol.67 (6), p.808-815

1996

Volltextzugriff (PDF)

Inhibition of cytokine production by cyclosporin A and transforming growth factor β

The Journal of experimental medicine, 1987-08, Vol.166 (2), p.571-576

1987

Volltextzugriff (PDF)

Recombinant Human Tumor Necrosis Factor-$\alpha $: Effects on Proliferation of Normal and Transformed Cells in vitro

Science (American Association for the Advancement of Science), 1985-11, Vol.230 (4728), p.943-945

1985

Volltextzugriff (PDF)

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha

Journal of leukocyte biology, 1987-03, Vol.41 (3), p.196-204

1987

Volltextzugriff (PDF)

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

The Journal of experimental medicine, 1992, Vol.175 (1), p.217-225

1992

Volltextzugriff (PDF)

Interferons and Tumor Necrosis Factors Have Similar Catabolic Effects on 3T3 L1 Cells

Proceedings of the National Academy of Sciences - PNAS, 1986-11, Vol.83 (21), p.8313-8317

1986

Volltextzugriff (PDF)

Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells

Molecular and Cellular Biology, 1991-02, Vol.11 (2), p.979-986

1991

Volltextzugriff (PDF)

Amplified Expression of the HER2/ERBB2 Oncogene Induces Resistance to Tumor Necrosis Factor α in NIH 3T3 Cells

Proceedings of the National Academy of Sciences - PNAS, 1988-07, Vol.85 (14), p.5102-5106

1988

Volltextzugriff (PDF)

c-erbB-2 expression in different histological types of invasive breast carcinoma

Journal of clinical pathology, 1991-03, Vol.44 (3), p.211-214

1991

Volltextzugriff (PDF)

p185HER2 signal transduction in breast cancer cells

The Journal of biological chemistry, 1991-08, Vol.266 (22), p.14300-14306

1991

Volltextzugriff (PDF)

Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression

Clinical cancer research, 2018-10, Vol.24 (19), p.4798-4807

2018

Volltextzugriff (PDF)

Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody

American journal of respiratory cell and molecular biology, 1993-10, Vol.9 (4), p.448

1993

Volltextzugriff (PDF)

Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides

Molecular and Cellular Biology, 1985-04, Vol.5 (4), p.768-779

1985

Volltextzugriff (PDF)

Identification of heregulin, a specific activator of p185erbB2

Science (American Association for the Advancement of Science), 1992-05, Vol.256 (5060), p.1205-1210

1992

Volltextzugriff (PDF)

Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors

The American journal of pathology, 1987-09, Vol.128 (3), p.410-425

1987

Volltextzugriff (PDF)

NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against β-Lactamase-Producing Strains

Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1262-1268

2002

Volltextzugriff (PDF)

Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells

The Journal of immunology (1950), 1987-09, Vol.139 (6), p.1891

1987

Volltextzugriff (PDF)

1 – 25 von 1.978

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.796)
Mit Volltextzugriff
(1.836)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

A recombinant human enzyme for enhanced interstitial transport of therapeutics

Humanization of an anti-p185HER2 antibody for human cancer therapy

p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

Herceptin

Tumor Necrosis Factor: A Potent Effector Molecule for Tumor Cell Killing by Activated Macrophages

Macrophage-induced angiogenesis is mediated by tumour necrosis factor- α

Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

Inhibition of cytokine production by cyclosporin A and transforming growth factor β

Recombinant Human Tumor Necrosis Factor-$\alpha $: Effects on Proliferation of Normal and Transformed Cells in vitro

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

Interferons and Tumor Necrosis Factors Have Similar Catabolic Effects on 3T3 L1 Cells

Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells

Amplified Expression of the HER2/ERBB2 Oncogene Induces Resistance to Tumor Necrosis Factor α in NIH 3T3 Cells

c-erbB-2 expression in different histological types of invasive breast carcinoma

p185HER2 signal transduction in breast cancer cells

Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression

Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody

Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides

Identification of heregulin, a specific activator of p185erbB2

Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors

NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against β-Lactamase-Producing Strains

Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells

Suchergebnisse filtern